Pzena Investment Management Inc is an asset management business based in the US. Pzena Investment Management shares (PZN) are listed on the NYSE and all prices are listed in US Dollars. Pzena Investment Management employs 143 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $6.53 |
|---|---|
| 52-week range | $6.07 - $11.19 |
| 50-day moving average | $6.68 |
| 200-day moving average | $8.92 |
| Wall St. target price | $13.00 |
| PE ratio | 7.5685 |
| Dividend yield | $0.62 (9.37%) |
| Earnings per share (TTM) | $0.91 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $6.53 from 2022-06-29
| 1 week (2022-06-24) | -5.50% |
|---|---|
| 1 month (2022-05-28) | N/A |
| 3 months (2022-04-01) | -20.07% |
| 6 months (2021-12-31) | -31.05% |
| 1 year (2021-07-01) | -41.70% |
|---|---|
| 2 years (2020-07-01) | 19.60% |
| 3 years (2019-07-01) | 8.62 |
| 5 years (2017-06-30) | 10.16 |
Valuing Pzena Investment Management stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Pzena Investment Management's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Pzena Investment Management's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 8x. In other words, Pzena Investment Management shares trade at around 8x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Pzena Investment Management's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.11. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Pzena Investment Management's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Pzena Investment Management's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $110.6 million.
The EBITDA is a measure of a Pzena Investment Management's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $206.2 million |
|---|---|
| Operating margin TTM | 53.07% |
| Gross profit TTM | $122.3 million |
| Return on assets TTM | 35.79% |
| Return on equity TTM | 84.79% |
| Profit margin | 8.39% |
| Book value | $2.18 |
| Market capitalisation | $117.1 million |
TTM: trailing 12 months
Dividend payout ratio: 66.44% of net profits
Recently Pzena Investment Management has paid out, on average, around 66.44% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 9.37% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Pzena Investment Management shareholders could enjoy a 9.37% return on their shares, in the form of dividend payments. In Pzena Investment Management's case, that would currently equate to about $0.62 per share.
Pzena Investment Management's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Pzena Investment Management's most recent dividend payout was on 19 May 2022. The latest dividend was paid out to all shareholders who bought their shares by 27 April 2022 (the "ex-dividend date").
Over the last 12 months, Pzena Investment Management's shares have ranged in value from as little as $6.07 up to $11.1935. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Pzena Investment Management's is 1.2877. This would suggest that Pzena Investment Management's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Pzena Investment Management, Inc. is a employee owned investment manager. The firm manages equity mutual funds for its clients. It invests in the public equity markets. The firm provides its services to Individuals, high net worth individuals, investment companies, pooled investment vehicles, charitable organizations, pension and profit sharing plans, state or municipal government entities, charitable organizations, other investment advisers, insurance companies, sovereign wealth funds and foreign official institutions, corporations or other businesses. The firm uses a combination of fundamental analysis to make its investments. The firm employs a combination of in-house and external research to make its investments.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.